Clinical trial Recruiting at 1 site Observational Ages 18 and up

Lymphovenous bypass procedure to prevent lymphedema after lymphadenectomy

Official title: Prophylactic Lymphovenous Bypass Procedure Following Inguinal Lymphadenectomy or Pelvic Lymphadenectomy: A Prospective Observational Study

Run by M.D. Anderson Cancer Center · NCT05992909 · Data updated 2026-11-12

This study is testing if a special surgery called lymphovenous bypass can help prevent swelling in the legs after patients have lymph nodes removed.

More Lymphadenectomy trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment20 (estimated)
SponsorM.D. Anderson Cancer Center
Academic / other
Locations1 site (Houston, Texas)
StatusRecruiting
StartedAugust 2, 2023
Main results expectedAugust 1, 2027
Study endsAugust 1, 2027
Registry record updatedJune 16, 2026
Trial IDNCT05992909 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older who are scheduled for inguinal lymphadenectomy.

Probably not a fit

Patients taking anticoagulants, pregnant individuals, those with a BMI over 50, or those unable to commit to follow-up may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate whether performing a lymphovenous bypass (LVB) procedure during inguinal lymphadenectomy (ILND) can prevent the development of lymphedema. It will compare outcomes of patients who receive the LVB procedure at the time of surgery with those who undergo standard surgery without the intervention. The study will involve patients aged 18 and older who are undergoing ILND and are willing to participate. The goal is to gather data on the protective benefits of LVB surgery.

Why it matters

Potential benefit: If successful, this approach could significantly reduce the incidence of lymphedema in patients undergoing lymphadenectomy.

How similar studies have gone: While this approach is innovative, similar studies have not been widely reported, indicating that this may be a novel investigation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Eligibility Criteria:

1. Patients greater than or equal to 18 years of age.
2. Patients willing to participate.
3. Patients able to complete informed consent.
4. Patients undergoing ILND and/or PLND.

Exclusion Criteria:

1. Patients taking anticoagulants within 7 days prior to surgery.
2. Patients that are known to be pregnant at the time of surgery.
3. Patients are available for follow-up less than 18 months or do not undergo measurements within the scheduled period.
4. Patients with BMI greater than 50.0.

Where it's running

  • MD Anderson Cancer Center
    Houston, Texas, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.